NasdaqCM - Delayed Quote USD
Elevai Labs Inc. (ELAB)
At close: November 6 at 4:00 PM EST
After hours: 7:59 PM EST
Breakdown
12/31/2023
12/31/2022
12/31/2021
Total Assets
5,189.9180
1,892.1830
666.2500
Total Liabilities Net Minority Interest
1,362.8420
760.8730
215.6220
Total Equity Gross Minority Interest
3,827.0760
1,131.3100
450.6280
Total Capitalization
3,827.0760
1,131.3100
450.6280
Preferred Stock Equity
--
0.5710
0.3850
Common Stock Equity
3,827.0760
1,130.7390
450.2430
Capital Lease Obligations
210.4890
283.2170
--
Net Tangible Assets
3,827.0760
1,131.3100
450.6280
Working Capital
3,622.0910
963.0500
420.9030
Invested Capital
3,827.0760
1,130.7390
450.2430
Tangible Book Value
3,827.0760
1,130.7390
450.2430
Total Debt
210.4890
283.2170
--
Share Issued
17,329.6150
17,329.6150
17,329.6150
Ordinary Shares Number
17,329.6150
17,329.6150
17,329.6150
12/31/2021 - 11/21/2023
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
GRI GRI Bio, Inc.
0.9500
-4.04%
BNOX Bionomics Limited
0.2789
-43.43%
ATHA Athira Pharma, Inc.
0.7000
-6.67%
ADTX Aditxt, Inc.
0.4750
+0.30%
ENSC Ensysce Biosciences, Inc.
0.5503
+5.42%
TOVX Theriva Biologics, Inc.
1.9700
0.00%
ZVSA ZyVersa Therapeutics, Inc.
1.5400
-39.37%
PBM Psyence Biomedical Ltd.
0.0612
-6.99%
NLSP NLS Pharmaceutics AG
4.0900
+1.24%
CDT Conduit Pharmaceuticals Inc.
0.1073
+2.00%